Anastomosis Devices Market To Reach a Value of USD 5,535.1 Million by 2030

Anastomosis Devices Market Is Dominated by the North American Region

Anastomosis Devices Market To Reach a Value of USD 5,535.1 Million by 2030

The total revenue generated by the anastomosis devices market was USD 2,912.7 million in 2022, which will reach USD 5,535.1 million by 2030, powering at a compound annual growth rate of 8.5% by the end of this decade, as stated by P&S Intelligence, a market research company.

The disposable category had the larger share of revenue, about 80%, in the past. This is because of an extensive range of these items being obtainable and increased penetration of the marketplace. Furthermore, numerous industry players manufacture disposable items.

Also, these products reduce the possibility of SSI, cross-contamination, and further infections associated with healthcare. These instruments also have the advantage of not requiring to be reprocessed in between applications, lowering the cost of reprocessing and accelerates the overall procedures. Hence, the said advantages will power this category steadily.

The cardiovascular and thoracic surgeries category had the largest share of revenue, over 60%. This is owing to the constant increase in the occurrence of CVDs, which are a main contributor to the increase in the heart surgery count. As per the WHO, there are about 17.9 million deaths happen because of CVDs.

Alternatively, because of the increasing frequency of colorectal cancer and other gastrointestinal ailments that require bowel resection, the gastrointestinal surgeries category, including large bowel resections and colorectal procedures, will experience considerable growth rate of approximately around 10% in the near future.

An increase in in operations performed globally will fuel the advance of the industry. This is owing to the increase in the global senior population and a increase in the incidence of lifestyle diseases including, diabetes, hypertension, cancer, obesity, and heart diseases.

Thus, the requirement for anastomosis systems will increase together with the increasing surgery count. Also, these tools enable quicker healing, less scarring and less loss of blood.

North America dominated the anastomosis devices market with 45%. Multiple CVD indications, for example CAD and strokes, and gastric malignancies, including lymphoma and adenocarcinoma, are becoming more predominant in the region, leading to an increase in procedures and a following increase in the requirement for anastomosis systems.

Europe followed North America in terms of revenue generation, having 30% share in the recent past. The growth of the industry has a lot to do with the increasing elderly population; increasing prevalence of chronic ailments; existence of industry mavens; and increasing number of product launches.

There is an increase in the number of target illnesses all over the world, that is why the demand for anastomosis devices in the market will be on the rise in the years to come.

SOURCE: P&S Intelligence

Click Here To See More